Literature DB >> 19321797

Selective brain uptake and behavioral effects of the cyanobacterial toxin BMAA (beta-N-methylamino-L-alanine) following neonatal administration to rodents.

Oskar Karlsson1, Nils Gunnar Lindquist, Eva B Brittebo, Erika Roman.   

Abstract

Cyanobacteria are extensively distributed in terrestrial and aquatic environments all over the world. Most cyanobacteria can produce the neurotoxin beta-N-methylamino-L-alanine (BMAA), which has been detected in several water systems and could accumulate in food chains. The aim of the study was to investigate the transfer of BMAA to fetal and neonatal brains and the effects of BMAA on the development of behavioral characteristics during the brain growth spurt (BGS) in rodents. Pregnant and neonatal mice were given an injection of (3)H-BMAA on gestational day 14 and postnatal day (PND) 10, respectively, and processed for tape-section autoradiography. The study revealed transplacental transfer of (3)H-BMAA and a significant uptake in fetal mouse brain. The radioactivity was specifically located in the hippocampus, striatum, brainstem, spinal cord and cerebellum of 10-day-old mice. The effect of repeated BMAA treatment (200 or 600 mg/kg s.c.) during BGS on rat behavior was also studied. BMAA treatment on PND 9-10 induced acute alterations, such as impaired locomotor ability and hyperactivity, in the behavior of neonatal rats. Furthermore, rats given the high dose of BMAA failed to habituate to the test environment when tested at juvenile age. In conclusion, the results demonstrated that BMAA was transferred to the neonatal brain and induced significant changes in the behavior of neonatal rats following administration during BGS. The observed behavioral changes suggest possible cognitive impairment. Increased information on the long-term effects of BMAA on cognitive function following fetal and neonatal exposure is required for assessment of the risk to children's health.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321797     DOI: 10.1093/toxsci/kfp062

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  29 in total

Review 1.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

2.  Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure.

Authors:  Sara Jonasson; Johan Eriksson; Lotta Berntzon; Zdenek Spácil; Leopold L Ilag; Lars-Olof Ronnevi; Ulla Rasmussen; Birgitta Bergman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

3.  Intravenous injection of l-BMAA induces a rat model with comprehensive characteristics of amyotrophic lateral sclerosis/Parkinson-dementia complex.

Authors:  Ke-Wei Tian; Hong Jiang; Bei-Bei Wang; Fan Zhang; Shu Han
Journal:  Toxicol Res (Camb)       Date:  2015-11-10       Impact factor: 3.524

4.  Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading.

Authors:  Vanessa X Tan; Benjamin Lassus; Chai K Lim; Philippe Tixador; Josquin Courte; Alban Bessede; Gilles J Guillemin; Jean-Michel Peyrin
Journal:  Neurotox Res       Date:  2017-08-25       Impact factor: 3.911

5.  Probing the lipid chemistry of neurotoxin-induced hippocampal lesions using multimodal imaging mass spectrometry.

Authors:  Jörg Hanrieder; Oskar Karlsson; Eva Brittebo; Per Malmberg; Andrew G Ewing
Journal:  Surf Interface Anal       Date:  2014-03-28       Impact factor: 1.607

6.  Perinatal Exposure to the Cyanotoxin β-N-Méthylamino-L-Alanine (BMAA) Results in Long-Lasting Behavioral Changes in Offspring-Potential Involvement of DNA Damage and Oxidative Stress.

Authors:  Anthony Laugeray; Asma Oummadi; Clément Jourdain; Justyne Feat; Géraldine Meyer-Dilhet; Arnaud Menuet; Karen Plé; Marion Gay; Sylvain Routier; Stéphane Mortaud; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

7.  Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.

Authors:  Mohammad Arif; Syed Faraz Kazim; Inge Grundke-Iqbal; Ralph M Garruto; Khalid Iqbal
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

8.  The Evaluation of BMAA Inhalation as a Potential Exposure Route Using a rat Model.

Authors:  Laura Louise Scott; Simoné Downing; Timothy Grant Downing
Journal:  Neurotox Res       Date:  2017-05-03       Impact factor: 3.911

9.  Transport of BMAA into Neurons and Astrocytes by System xc.

Authors:  Rebecca Albano; Doug Lobner
Journal:  Neurotox Res       Date:  2017-05-03       Impact factor: 3.911

10.  High resolution metabolite imaging in the hippocampus following neonatal exposure to the environmental toxin BMAA using ToF-SIMS.

Authors:  Jörg Hanrieder; Lorenz Gerber; Åsa Persson Sandelius; Eva B Brittebo; Andrew G Ewing; Oskar Karlsson
Journal:  ACS Chem Neurosci       Date:  2014-05-09       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.